SEC Form 4 · accession 0001225208-17-004175
KIMBERLY CLARK CORP · KMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas J. Mielke
Officer — SVP - General Counsel
Period of report
Feb 17, 2017
Accepted (ET)
Feb 22, 2017 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000055785
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 17, 2017 | M | 9,314 | $110.72 | A | 27,459 | D | |
| Common Stock | Feb 17, 2017 | M | 8,894 | $75.2203 | A | 36,353 | D | |
| Common StockF1 | Feb 17, 2017 | S | 18,208 | $131.53 | D | 18,145 | D | |
| Common StockF2 | holding | — | — | — | 1,187 | I | By Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3,F4,F5 | $110.72 | Feb 17, 2017 | M | 9,314 | D | — | Apr 29, 2025 | Common Stock | 9,314 | 21,733 | D |
| Stock Option (Right to Buy)F3,F4,F6 | $75.2203 | Feb 17, 2017 | M | 8,894 | D | — | May 2, 2022 | Common Stock | 8,894 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $131.50 to $131.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Shares are held by the trustee of the Kimberly-Clark Corporation 401(k) and Profit Sharing Plan and beneficially owned by the reporting person's wife as of a recent practicable date.
- F3Employee stock option granted under the Kimberly-Clark Corporation 2011 Equity Participation Plan.
- F4All historical share and stock option exercise price data in this Form 4 have been adjusted to reflect the Corporation's spin-off of its wholly owned subsidiary Halyard Health, Inc. on October 31, 2014. The adjustments were made to preserve the intrinsic value of the reporting person's stock options existing prior to the spin-off.
- F5The option vests in three annual installments of 30%, 30% and 40%, beginning on April 29, 2016.
- F6Stock options are fully vested and exercisable.